Clincosm LogoSign in Get a demo

Retinal Vein Occlusion

Showing NaN - NaN of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Retinopathy, Retinal Vein Occlusion, Hypertension,Essential Trial in Baltimore (Swept-Source OCT Angiography,

Recruiting
  • Diabetic Retinopathy
  • +3 more
  • Swept-Source OCT Angiography
  • +3 more
  • Baltimore, Maryland
    Wilmer Eye Institute
Aug 10, 2022

Patients Treated With ranibizUmab for REtinal Vein Occlusion

Terminated
  • Retinal Vein Occlusion
    • Baltimore, Maryland
      Wilmer Eye Institute
    Oct 8, 2021

    Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)

    Terminated
    Has Results
    • Macular Edema
    • Retinal Vein Occlusion
    • suprachoroidal CLS-TA
    • +2 more
    • Phoenix, Arizona
    • +91 more
    Apr 22, 2021

    Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)

    Terminated
    Has Results
    • Macular Edema
    • Retinal Vein Occlusion
    • suprachoroidal CLS-TA
    • +2 more
    • Peoria, Arizona
    • +109 more
    Mar 18, 2021

    Macular Edema, Retinal Vein Occlusion Trial in United States (4 mg CLS-TA, Sham, IVT aflibercept)

    Completed
    Has Results
    • Macular Edema
    • Retinal Vein Occlusion
    • 4 mg CLS-TA
    • +2 more
    • Phoenix, Arizona
    • +13 more
    Jan 18, 2021

    Retinal Vein Occlusion Trial in Baltimore (AKB-9778)

    Completed
    • Retinal Vein Occlusion
    • Baltimore, Maryland
      Wilmer Eye Institute
    Jun 25, 2018

    Precision of the Microperimetry Function of the Spectral OCT/SLO

    Completed
    Has Results
    • Age-Related Macular Degeneration
    • +8 more
      • Fort Lauderdale, Florida
      • +2 more
      Apr 3, 2017

      Retinal Vein Occlusion Trial in Baltimore (Ranibizumab 0.5mg (monthly), Ranibizumab 2.0mg (monthly), Pro re nata (prn)

      Completed
      Has Results
      • Retinal Vein Occlusion
      • Ranibizumab 0.5mg (monthly)
      • +3 more
      • Baltimore, Maryland
        Wilmer Eye Institute at Johns Hopkins University
      Feb 16, 2016

      Retinal Vein Occlusion Trial in Baltimore (dexamethasone implant)

      Completed
      Has Results
      • Retinal Vein Occlusion
      • dexamethasone implant
      • Baltimore, Maryland
        Wilmer Eye Institute
      Apr 2, 2015

      Macular Edema, Retinal Vein Occlusion Trial in Baltimore (Intravitreal injection of ranibizumab .3 dose, Intravitreal injection

      Completed
      Has Results
      • Macular Edema
      • Retinal Vein Occlusion
      • Intravitreal injection of ranibizumab .3 dose
      • Intravitreal injection of Ranibizumab .5 dose
      • Baltimore, Maryland
        Wilmer Eye Institute
      Oct 7, 2013